European Neuropsychopharmacology

Editorial Board
pp. CO2-CO2(1)

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
pp. 87-92(6)
Authors: Bhanji N.H.; Chouinard G.; Margolese H.C.

Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study
pp. 93-104(12)
Authors: Watanabe H.; Muramatsu Y.; Kurosaki R.; Michimata M.; Matsubara M.; Imai Y.; Araki T.

Gender in obsessive-compulsive disorder: clinical and genetic findings
pp. 105-113(9)
Authors: Lochner C.; Hemmings S.M.J.; Kinnear C.J.; Moolman-Smook J.C.; Corfield V.A.; Knowles J.A.; Niehaus D.J.H.; Stein D.J.

Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
pp. 115-119(5)
Author: Melkersson K.

Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy
pp. 121-125(5)
Authors: Nahshoni E.; Manor N.; Bar F.; Stryjer R.; Zalsman G.; Weizman A.

Monosialoganglioside (GM₁) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats
pp. 127-133(7)
Authors: Perry J.C.; Vital M.A.B.F.; Frussa-Filho R.; Tufik S.; Palermo-Neto J.

Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses
pp. 135-142(8)
Authors: Papakostas G.I.; Ongur D.; Iosifescu D.V.; Mischoulon D.; Fava M.

Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs
pp. 143-150(8)
Authors: Corson T.W.; Woo K.K.; Li P.P.; Warsh J.J.

Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study
pp. 151-155(5)
Authors: Pitchot W.; Wauthy J.; Legros J.-J.; Ansseau M.

Reduced anxious behavior in mice lacking the CCK2 receptor gene
pp. 157-161(5)
Authors: Horinouchi Y.; Akiyoshi J.; Nagata A.; Matsushita H.; Tsutsumi T.; Isogawa K.; Noda T.; Nagayama H.

Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice-an isobolographic analysis
pp. 163-172(10)
Authors: Borowicz K.K.; L J.; Czuczwar S.J.

Corrigendum to ''Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial'' [Eur. Neuropsychoparmacol. 13 (2003) 267-271]
pp. 173-173(1)
Authors: Su K.-P.; Huang S.-Y.; Chiu C.-C.; Shen W.W.